Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 8,007 shares at $16.01 ($128K) on 2023-07-21, disclosed to the SEC on 2023-07-21.
Scheduled sale ($128k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.08 | 207 | $3K | 2.6% |
| 2 | $16.01 | 3,900 | $62K | 48.7% |
| 3 | $16.01 | 3,900 | $62K | 48.7% |
| Total | $16.01 avg | 8,007 | $128K | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |